SOURCE: Skystar

Skystar

September 06, 2011 11:07 ET

Skystar Bio-Pharmaceutical to Present at Rodman & Renshaw Annual Global Investment Conference

XI'AN, CHINA--(Marketwire - Sep 6, 2011) - Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that the Company will present at the Rodman & Renshaw Annual Global Investment Conference at The Waldorf-Astoria in New York City on Tuesday, September 13, 2011 at 10:00 am Eastern time.

The conference will include a series of one-on-one meetings with institutional investors. Investors interested in scheduling a meeting with the management team can facilitate a request by contacting the Company at skystar@grayling.com or alternatively contact their Rodman & Renshaw representative directly.

Offsite management meetings with institutional investors in New York City with Skystar's management can be arranged, please contact Christopher Chu for more details.

A slide archive of the presentation will be available under the "Events and Presentations" page on the "Investor Relations" section of the Company's website at http://www.ir-site.com/skystar/events.asp.

To request a one-on-one meeting or to be added to Skystar's email list, please contact Christopher Chu at skystar@grayling.com or call 646-284-9426.

To be added to the Company's email distribution for future news releases, please send your request to skystar@grayling.com.

About Skystar Bio-Pharmaceutical Company
Skystar is a China-based developer and distributor of veterinary healthcare and medical care products. Skystar has four product lines (veterinary medicines, micro-organisms, vaccines and feed additives) and 263 products. Skystar has formed strategic sales distribution networks covering 29 provinces throughout China. For additional information, please visit http://www.skystarbio-pharmaceutical.com.

Contact Information

  • Contacts:

    Skystar Bio-Pharmaceutical Company
    Scott Cramer
    Director - Director Corporate Development and U.S. Representative
    (407) 645-4433

    Grayling
    Investor Relations
    Christopher Chu
    (646) 284-9426
    Email Contact